Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion type Assertion NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_head.
- NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_provenance.
- NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion evidence source_evidence_literature NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_provenance.
- NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion SIO_000772 23633485 NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_provenance.
- NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion wasDerivedFrom befree-20150227 NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_provenance.
- NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_assertion wasGeneratedBy ECO_0000203 NP623149.RA5iCF0c5e455eRJfOLuRhVm7hq8plgWhDIeSnWVkasrY130_provenance.